Drug Protects Mice from Heart Failure Post-Heart Attack
Cedars-Sinai investigators identify a potential way to avert heart failure for survivors of heart attacks.
Cedars-Sinai investigators identify a potential way to avert heart failure for survivors of heart attacks.
Heart failure patients with mitral regurgitation experienced better outcomes and improved quality of life with a minimally invasive valve clip procedure compared to standard medication alone.
A study unveils unexpected mechanisms of SGLT2 inhibitors, challenging the assumption that their beneficial, organ-protective effects stem from a diuretic effect.
Read MoreA clinical trial found that an investigational drug improved exercise capacity in patients with hypertrophic cardiomyopathy by increasing their peak oxygen uptake.
Read MoreResearch presented at the ESC’s annual congress shows a significant survival benefit for heart failure patients who receive COVID-19 vaccinations.
Read MoreThe American College of Cardiology and American Heart Association’s latest recommendations include a new drug class and low-to-moderate exercise.
Read MoreA multicenter study finds that a drug initially approved for type 2 diabetes benefits patients after admission to the hospital for acute heart failure.
Read MoreThe Centers for Medicare and Medicaid Services announced that it would allow health plans under Medicare Part D to cover Wegovy and other weight-loss medications if they receive FDA approval for an additional medically accepted indication.
Read MoreA new study in mice suggests regular use of acetaminophen, the active ingredient in Tylenol and many other pain medications, at moderate to high doses may pose a risk to heart health.
Read MoreA new study shows treating anxiety and depression can lead to a 75% reduction in emergency room visits and rehospitalizations for heart disease patients.
Read MoreAprocitentan, targeting the endothelin pathway, offers a new approach for managing hypertension alongside existing medications.
Read More